Veterinary Medicines

Tricaine Pharmaq 1000 mg/g Powder for Solution for Fish Treatment

Authorised
  • Tricaine mesilate
Download as PDF

Product identification

Medicine name:
Tricaine Pharmaq 1000 mg/g Powder for Solution for Fish Treatment
Tricaine Pharmaq 1000 mg/g pulver til behandlingsoppløsning til fisk
Active substance:
  • Tricaine mesilate
Target species:
  • Ornamental fish
  • Other fish
Route of administration:
  • Dipping

Product details

Active substance and strength:
  • Tricaine mesilate
    1000.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for solution for fish treatment
Withdrawal period by route of administration:
  • Dipping
    • Ornamental fish
      • Fish meat
        70
        degree day
    • Other fish
      • Fish meat
        70
        degree day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Available in:
  • Norway
Package description:
  • High Density Polyethylene (HDPE) tamper resistant tubs closed with an integral, tamper evident, low density polyethylene cap (snap on) or polypropylene screw cap containing 1000 g.
  • High Density Polyethylene (HDPE) tamper resistant tubs closed with an integral, tamper evident, low density polyethylene cap (snap on) or polypropylene screw cap containing 250 g.
  • High Density Polyethylene (HDPE) tamper resistant tubs closed with an integral, tamper evident, low density polyethylene cap (snap on) or polypropylene screw cap containing 100 g.
  • High Density Polyethylene (HDPE) tamper resistant tubs closed with an integral, tamper evident, low density polyethylene cap (snap on) or polypropylene screw cap containing 25 g.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharmaq AS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmaq Limited
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 12-8906
Date of authorisation status change:
Reference member state:
  • Norway
Procedure number:
  • NO/V/0012/001
Concerned member states:
  • Greece
  • Iceland
  • Ireland
  • Italy
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 19/09/2025
Download

Combined File of all Documents

English (PDF)
Published on: 25/07/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 19/09/2025
Download